Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma

被引:11
作者
Chakraborty, Rajshekhar [1 ]
Cheruvalath, Heloise [2 ]
Patwari, Anannya [2 ]
Szabo, Aniko [2 ]
Schinke, Carolina [3 ]
Dhakal, Binod [2 ]
Lentzsch, Suzanne [1 ]
D'Souza, Anita [2 ]
Mohyuddin, Ghulam Rehman [4 ]
Julian, Kelley [4 ]
Midha, Shonali [5 ]
Costello, Patrick [5 ]
Kaiser, Martin [6 ]
Hing, Melissa Ng Liet [7 ,8 ,9 ]
Harrison, Simon J. [7 ,8 ,9 ]
Cliff, Edward R. Scheffer [7 ,8 ,9 ]
Mohan, Meera [2 ]
机构
[1] Columbia Univ, Irving Med Ctr, New York, NY 10027 USA
[2] Med Coll Wisconsin, Milwaukee, WI USA
[3] Univ Arkansas Med Sci, Little Rock, AR USA
[4] Univ Utah, Huntsman Canc Ctr, Salt Lake City, UT 84112 USA
[5] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[6] Inst Canc Res, London, England
[7] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Australia
[8] Peter MacCallum Canc Ctr, Dept Clin Haematol, Melbourne, Australia
[9] Royal Melbourne Hosp, Melbourne, Australia
关键词
MULTIPLE-MYELOMA;
D O I
10.1038/s41408-024-01114-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:4
相关论文
共 19 条
[1]  
Bar N., 2023, Blood, V142, P2011
[2]   Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study [J].
Budde, Lihua E. ;
Sehn, Laurie H. ;
Matasar, Matthew ;
Schuster, Stephen J. ;
Assouline, Sarit ;
Giri, Pratyush ;
Kuruvilla, John ;
Canales, Miguel ;
Dietrich, Sascha ;
Fay, Keith ;
Ku, Matthew ;
Nastoupil, Loretta ;
Cheah, Chan Yoon ;
Wei, Michael C. ;
Yin, Shen ;
Li, Chi-Chung ;
Huang, Huang ;
Kwan, Antonia ;
Penuel, Elicia ;
Bartlett, Nancy L. .
LANCET ONCOLOGY, 2022, 23 (08) :1055-1065
[3]   Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody [J].
Chari, Ajai ;
Minnema, Monique C. ;
Berdeja, Jesus G. ;
Oriol, Albert ;
van de Donk, Niels W. C. J. ;
Rodriguez-Otero, Paula ;
Askari, Elham ;
Mateos, Maria-Victoria ;
Costa, Luciano J. ;
Caers, Jo ;
Verona, Raluca ;
Girgis, Suzette ;
Yang, Shiyi ;
Goldsmith, Rachel B. ;
Yao, Xiang ;
Pillarisetti, Kodandaram ;
Hilder, Brandi W. ;
Russell, Jeffery ;
Goldberg, Jenna D. ;
Krishnan, Amrita .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (24) :2232-2244
[4]   Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma [J].
Cliff, Edward R. Scheffer ;
Reynolds, Gemma ;
Popat, Rakesh ;
Teh, Benjamin W. ;
Kesselheim, Aaron S. ;
Mohyuddin, Ghulam Rehman .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (10) :1949-+
[5]   Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents [J].
Cohen, Adam D. ;
Mateos, Maria-Victoria ;
Cohen, Yael C. ;
Rodriguez-Otero, Paula ;
Paiva, Bruno ;
van de Donk, Niels W. C. J. ;
Martin, Thomas ;
Suvannasankha, Attaya ;
De Braganca, Kevin C. ;
Corsale, Christina ;
Schecter, Jordan M. ;
Varsos, Helen ;
Deraedt, William ;
Wang, Liwei ;
Vogel, Martin ;
Roccia, Tito ;
Xu, Xiaoying ;
Mistry, Pankaj ;
Zudaire, Enrique ;
Akram, Muhammad ;
Nesheiwat, Tonia ;
Pacaud, Lida ;
Avivi, Irit ;
San-Miguel, Jesus .
BLOOD, 2023, 141 (03) :219-230
[6]   Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial [J].
Costa, Luciano J. ;
Chhabra, Saurabh ;
Medvedova, Eva ;
Dholaria, Bhagirathbhai R. ;
Schmidt, Timothy M. ;
Godby, Kelly N. ;
Silbermann, Rebecca ;
Dhakal, Binod ;
Bal, Susan ;
Giri, Smith ;
D'Souza, Anita ;
Hall, Aric C. ;
Hardwick, Pamela ;
Omel, James ;
Cornell, Robert F. ;
Hari, Parameswaran ;
Callander, Natalie S. .
LANCET HAEMATOLOGY, 2023, 10 (11) :e890-e901
[7]   A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen x CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma [J].
D'Souza, Anita ;
Shah, Nina ;
Rodriguez, Cesar ;
Voorhees, Peter M. ;
Weisel, Katja ;
Bueno, Orlando F. ;
Pothacamury, Rajvineeth K. ;
Freise, Kevin J. ;
Yue, Susan ;
Ross, Jeremy A. ;
Polepally, Akshanth R. ;
Talati, Chetasi ;
Lee, Shane ;
Jin, Ziyi ;
Buelow, Ben ;
Vij, Ravi ;
Kumar, Shaji .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (31) :3576-+
[8]   Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma [J].
Dickinson, Michael J. ;
Carlo-Stella, Carmelo ;
Morschhauser, Franck ;
Bachy, Emmanuel ;
Corradini, Paolo ;
Iacoboni, Gloria ;
Khan, Cyrus ;
Wrobel, Tomasz ;
Offner, Fritz ;
Wu, Shang-Ju ;
Cartron, Guillaume ;
Hertzberg, Mark ;
Sureda, Anna ;
Perez-Callejo, David ;
Lundberg, Linda ;
Relf, James ;
Dixon, Mark ;
Clark, Emma ;
Humphrey, Kathryn ;
Hutchings, Martin ;
Trney, Marek .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (24) :2220-2231
[9]   The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma [J].
Hammons, Lindsay ;
Szabo, Aniko ;
Janardan, Abhishek ;
Bhatlapenumarthi, Vineel ;
Annyapu, Evanka ;
Dhakal, Binod ;
Al Hadidi, Samer ;
Radhakrishnan, Sabarinath Venniyil ;
Narra, Ravi ;
Bhutani, Divaya ;
Thanendrarajan, Sharmilan ;
Janz, Siegfried ;
Zangari, Maurizio ;
Lentzsch, Suzanne ;
van Rhee, Frits ;
Crescencio, Juan Carlos Rico ;
D'Souza, Anita ;
Chakraborty, Rajshekhar ;
Mohan, Meera ;
Schinke, Carolina .
HAEMATOLOGICA, 2024, 109 (03) :906-914
[10]   Patterns of Response to 200 Mg Linvoseltamab in Patients with Relapsed/Refractory Multiple Myeloma: Longer Follow-Up of the Linker-MM1 Study [J].
Jagannath, Sundar ;
Richter, Joshua ;
Dhodapkar, Madhav V. ;
Hoffman, James E. ;
Lee, Hans C. ;
Suvannasankha, Attaya ;
Shah, Mansi R. ;
Lentzsch, Suzanne ;
Zonder, Jeffrey A. ;
Baz, Rachid ;
Maly, Joseph J. ;
Namburi, Swathi ;
Wu, Ka Lung ;
Pianko, Matthew ;
Ye, Jing Christine ;
Silbermann, Rebecca ;
Min, Chang-Ki ;
Vekemans, Marie-Christiane ;
Munder, Markus ;
Byun, Ja Min .
BLOOD, 2023, 142